Influence of cardiovascular risk factors on antihypertensive treatment in general practice;Influence des facteurs de risque cardiovasculaires sur la prescription d'antihypertenseurs

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 8, 2001, Pages 846-850

  Vaur, L ^a   Amar, J ^a   Perret, M ^a   Bailleau, C ^a   Etienne, S ^a   Chamontin, B ^b  

^a SANOFI   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FRANCE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; DECISION MAKING; DIABETES COMPLICATIONS; FAMILY PRACTICE; FEMALE; FRANCE; GUIDELINE ADHERENCE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINES; RISK FACTORS; SMOKING; WORLD HEALTH;

EID: 0035574501     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Evolution of the Joint National Committee reports, 1988-1997
2. 1993 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting
3. Blood pressure, stroke and coronary heart disease
4. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
5. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension
6. First International Study of Infarct Survival Collaborative Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1
7. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
8. Health outcomes associated with calcium antagonists compared with other firstline antihypertensive therapies: A meta-analysis of randomised controlled trials
9. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials
10. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlortha-lidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
11. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
12. Prevalence, treatment and control of hypertension in the French population: Data from a survey on high blood pressure in general practice, 1994